Leveraging Advanced Analytical Tools To De-Risk Pharmaceutical Development

Drug development is a complex and costly endeavor. Despite significant advancements in understanding disease and creating new treatments, the process remains lengthy and risky. On average, it takes over a decade and billions of dollars to bring a new drug to market, with a staggering 90% failure rate.

This high rate of failure, coupled with the immense investment required, creates a formidable challenge for drug developers. To optimize resources and deliver safe, effective medicines, innovative strategies are essential.

Discover how three powerful tools can transform your drug development process:

• Solid form screening: Accelerate development and protect intellectual property.
• Physiologically based pharmacokinetic (PBPK) modeling: Gain deeper insights into drug behavior and patient variability.
• AI-enabled route scouting: Optimize synthetic routes for reduced cost and risk.

Access this e-book to learn how these tools can guide your compound from concept to clinical success.